BridgeMD
New treatment option for Postoperative Gastrointestinal Dysfunction (POGD)
Official title the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic Surgery
ClinicalTrials.gov ID: NCT07133620
What this study is testing
- What it's testing
- The purpose of this clinical trial is to understand the effect of percutaneous acupoint electrical stimulation on postoperative gastrointestinal dysfunction. It will also investigate the safety of percutaneous acupoint electrical stimulation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \> 18 years
- BMI \< 28 kg/m2
- ASA classification is I-III grade
- Laparoscopic urological procedures under general anesthesia, including but not limited to laparoscopic nephrectomy and laparoscopic radical...
- Normal comprehension ability, and the patient or his/her family members can cooperate in filling out the questionnaire
You likely can't join if
- Comprehensive assessment of severe cardiovascular, pulmonary and cerebrovascular diseases (such as severe coronary heart disease, valve diseases...
- Preoperative use of analgesic and gastrointestinal motility drugs
- TEAS contraindications (having electronic devices in the body, skin damage or infection at the stimulation site)
- Previous history of TEAS or electro-acupuncture treatment
- Previous history of gastrointestinal surgery, long-term gastrointestinal motility disorders and severe intestinal diseases
- Pregnancy
See the full eligibility criteria
- Age \> 18 years
- BMI \< 28 kg/m2
- ASA classification is I-III grade
- Laparoscopic urological procedures under general anesthesia, including but not limited to laparoscopic nephrectomy and laparoscopic radical prostatectomy for prostate cancer
- Normal comprehension ability, and the patient or his/her family members can cooperate in filling out the questionnaire
- Voluntary to sign the informed consent form
- Comprehensive assessment of severe cardiovascular, pulmonary and cerebrovascular diseases (such as severe coronary heart disease, valve diseases, respiratory failure, cerebral hemorrhage, cerebral infarction, etc.)
- Preoperative use of analgesic and gastrointestinal motility drugs
- TEAS contraindications (having electronic devices in the body, skin damage or infection at the stimulation site)
- Previous history of TEAS or electro-acupuncture treatment
- Previous history of gastrointestinal surgery, long-term gastrointestinal motility disorders and severe intestinal diseases
- Pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Xiamen, Fujian, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xiamen, Fujian, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.